Pardes Biosciences, Inc.

Pardes Biosciences, Inc.

Pardes BioSciences, Inc. uses COVID-19 research approach involving direct acting antivirals.

HQ location
Berkeley, United States
Launch date
Employees
Enterprise value
$250m
Share price
$2.16 PRDS
Authorizing premium user...